#منحة دكتوراه في بحوث السرطان المتعدية في جامعة كوينزلاند في أستراليا . المنحة شاملة راتب مغري ومزايا اخري لمدة ثلاث سنوات .
The University of Queensland Diamantina Institute (UQDI) was established in 2007 as the sixth research institute of The University of Queensland. The aim of the Institute is to develop a better understanding of the molecular and cellular basis of disease, and to translate that understanding into practical outcomes for patients. Based at the Translational Research Institute (TRI) at the Princess Alexandra Hospital teaching campus in Brisbane, the Institute has nearly 300 researchers and students who work closely with clinicians in the areas of cancer, immunology and genomic medicine. As the largest partner in TRI, UQDI has built and continues to expand major programs in Cancer, Immunology and Genomic Medicine research, with a particular focus on research aimed at development of new treatments. Details of the research interests of academic staff may be accessed on the Institute’s web site at http://www.di.uq.edu.au/research.
The Role
The successful Scholar will pursue a PhD degree in translational cancer research by conducting interdisciplinary research in the laboratory using a variety of experimental methods in the fields of molecular biology, cell biology, genetics and in vivo biology.
The Project
We have identified a number of novel potential therapeutic targets for the treatment of cancer. The misexpression of the genes that we identified may cause genomic instability, such as DNA damage or chromosome missegregation, a long-standing interest of our laboratory. Alternatively, their misexpression in cancers disturbs other processes, such as cell migration, that contribute to cancer initiation or progression. The goal of this project is to study how misexpression of these genes facilitates tumorigenesis. This will involve in vitro cell biological, as well as in vivo targeting approaches. This knowledge will be used for translational purposes: to develop new strategies for the treatment of cancer patients. This research project initially focuses on breast cancer. However, the approaches that will be developed may also be applied to other cancer types that are studied within our institute, in particular skin cancers, melanoma and lymphoma.
The Person
The candidate will have a 1st Class Honours, a Masters or an equivalent degree in science and a strong motivation to pursue a PhD degree. Prospective students will be provided with assistance to apply for a scholarship. Applicants should have basic knowledge in molecular biology, cell biology and genetics. Relevant laboratory experience, particularly in cell biology, is highly desirable.
Remuneration
The base stipend will be at the rate of AU$25,849.00 (2015 rate) per annum tax-free for three years with the possibility of a six month extension in approved circumstances.
Enquiries
For further information about the research project, please contact Dr Pascal Duijf (p.duijf@uq.edu.au). For information about applying for a scholarship and for the full terms and conditions, please visit the UQ Graduate School website at
To submit an application for this role, use the Apply button below. All applicants must supply the following documents: Cover letter, CV/Resume and Academic Records (indicating GPA scores/grades).
For information on completing the application process click here.
Applications close : 03 Jan 2015 (11:55 PM) E. Australia Standard Time
من فضلك شارك هذا الموضوع اذا اعجبك
ليست هناك تعليقات :
إرسال تعليق